Johnson & Johnson wins reversal of $72 million verdict over talc cancer risks

(Reuters) – Johnson & Johnson on Tuesday won the reversal of a $72 million verdict in favor of the family of a woman whose death from ovarian cancer they claimed stemmed from her use of&hellip

More Latest News

Leave a Reply

Your email address will not be published. Required fields are marked *